Answers are grounded in this paper and cite their sources.
In-silico models predict response factors for extractables and leachables in pharmaceuticals, suggesting improved safety assessment.
Ensuring safety of patients using pharmaceuticals and medical devices through chemical characterization requires accurate estimation of extractables and leachables to ensure tolerable risk from unintentional exposure to these chemicals. However, this is complicated by variability in chemical responses, particularly with mass spectrometry methods. High quality relative response factor predictions provide the opportunity for both expedited and more accurate quantitation in extractables and leachables analyses. In-silico prediction models were developed to test a wide variety of compounds, selected utilizing a physicochemical property coverage approach. Three neural network models, and associated sub-models, were applied to both positive and negative ionization modes for Liquid Chromatography Mass Spectrometry, and Gas Chromatography Mass Spectrometry methods. Mean absolute errors across all methods for training data was 0.47 and 0.65 for out-of-sample data, indicating high predictability of response factors for the compounds chosen by the model and a low likelihood that the data was overfit.Model performance was evaluated using a series of chemicals outside the training data set. When tested, predictive accuracy was greater than 60% of known values for 44 of the 49 chemicals tested (90%). This proof-of-concept work shows that sophisticated neural network modeling of response factor data is a potential solution for response factor variation.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: